FDA Import Refusal 112-2192253-9/1/18 — Boehringer Ingelheim Pharmaceuticals, Inc.
The FDA refused shipment 112-2192253-9/1/18 from Boehringer Ingelheim Pharmaceuticals, Inc. (United States) on Jul 16, 2006. The refused product falls under Drugs and Biologics — MELOXICAM (ANTI-INFLAMMATORY, PART II). Cited charge: 179 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jul 16, 2006
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 62YCA07 MELOXICAM (ANTI-INFLAMMATORY, PART II)
- Charges
- 179